In case you missed it: October 26 to October 30
It was a very busy week for the Contemporary Pediatrics team.
This week’s top articles included:
FDA approves Sklice for OTC use
Sklice (ivermectin) lotion, 0.5% has been approved for over-the-counter (OTC) use by the US Food and Drug Administration (FDA) in children aged 6 months and older.
The toll of COVID-19 and quarantine on college students’ mental health
The impact of COVID-19 on mental health is hard to measure. A report offers a look at how quarantine impacted the mental health of university students.
Impact of preoperative blood transfusion on postoperative outcomes in newborns
Many newborns get a blood transfusion because of surgery, but could preoperative blood transfusion do more harm than good?
Toll of environmental exposures on teen psychosocial stress
A new report looks into how environmental exposures can negatively impact an adolescent’s perceived stress.
Michael Daines, MD, discusses pediatric acute-onset neuropsychiatric syndrome
June 12th 2025Michael O. Daines, MD, outlines key diagnostic criteria and treatment challenges for pediatric acute-onset neuropsychiatric syndrome (PANS), emphasizing the need for multidisciplinary care and improved treatment access.
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
June 12th 2025Aaron Milstone, MD, MHS, emphasizes the role of pediatricians in educating families on infection prevention practices for infants in the NICU, where Staphylococcus aureus remains a serious threat.
